Logo image of MTX.DE

MTU AERO ENGINES AG (MTX.DE) Stock Fundamental Analysis

Europe - FRA:MTX - DE000A0D9PT0 - Common Stock

380.3 EUR
-10 (-2.56%)
Last: 10/14/2025, 3:21:15 PM
Fundamental Rating

5

Taking everything into account, MTX scores 5 out of 10 in our fundamental rating. MTX was compared to 49 industry peers in the Aerospace & Defense industry. MTX has only an average score on both its financial health and profitability. MTX is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year MTX was profitable.
MTX had a positive operating cash flow in the past year.
MTX had positive earnings in 4 of the past 5 years.
In the past 5 years MTX always reported a positive cash flow from operatings.
MTX.DE Yearly Net Income VS EBIT VS OCF VS FCFMTX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

MTX's Return On Assets of 7.23% is amongst the best of the industry. MTX outperforms 83.67% of its industry peers.
The Return On Equity of MTX (22.17%) is better than 77.55% of its industry peers.
The Return On Invested Capital of MTX (10.39%) is better than 67.35% of its industry peers.
Industry RankSector Rank
ROA 7.23%
ROE 22.17%
ROIC 10.39%
ROA(3y)2.55%
ROA(5y)2.41%
ROE(3y)8.72%
ROE(5y)7.98%
ROIC(3y)N/A
ROIC(5y)N/A
MTX.DE Yearly ROA, ROE, ROICMTX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 10.44%, MTX belongs to the best of the industry, outperforming 81.63% of the companies in the same industry.
In the last couple of years the Profit Margin of MTX has declined.
The Operating Margin of MTX (12.25%) is better than 75.51% of its industry peers.
MTX's Operating Margin has declined in the last couple of years.
MTX's Gross Margin of 16.90% is on the low side compared to the rest of the industry. MTX is outperformed by 77.55% of its industry peers.
In the last couple of years the Gross Margin of MTX has declined.
Industry RankSector Rank
OM 12.25%
PM (TTM) 10.44%
GM 16.9%
OM growth 3Y17.54%
OM growth 5Y-3.69%
PM growth 3Y17.24%
PM growth 5Y-3.73%
GM growth 3Y6.66%
GM growth 5Y-3.81%
MTX.DE Yearly Profit, Operating, Gross MarginsMTX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MTX is creating some value.
Compared to 1 year ago, MTX has about the same amount of shares outstanding.
MTX has more shares outstanding than it did 5 years ago.
MTX has a worse debt/assets ratio than last year.
MTX.DE Yearly Shares OutstandingMTX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MTX.DE Yearly Total Debt VS Total AssetsMTX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 3.15 indicates that MTX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.15, MTX is in the better half of the industry, outperforming 63.27% of the companies in the same industry.
MTX has a debt to FCF ratio of 19.44. This is a negative value and a sign of low solvency as MTX would need 19.44 years to pay back of all of its debts.
MTX has a worse Debt to FCF ratio (19.44) than 75.51% of its industry peers.
A Debt/Equity ratio of 0.56 indicates that MTX is somewhat dependend on debt financing.
MTX has a Debt to Equity ratio (0.56) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 19.44
Altman-Z 3.15
ROIC/WACC1.54
WACC6.76%
MTX.DE Yearly LT Debt VS Equity VS FCFMTX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

MTX has a Current Ratio of 1.39. This is a normal value and indicates that MTX is financially healthy and should not expect problems in meeting its short term obligations.
MTX has a better Current ratio (1.39) than 73.47% of its industry peers.
MTX has a Quick Ratio of 1.04. This is a normal value and indicates that MTX is financially healthy and should not expect problems in meeting its short term obligations.
MTX has a Quick ratio of 1.04. This is in the better half of the industry: MTX outperforms 77.55% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.04
MTX.DE Yearly Current Assets VS Current LiabilitesMTX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.03% over the past year.
Measured over the past 5 years, MTX shows a small growth in Earnings Per Share. The EPS has been growing by 6.33% on average per year.
The Revenue has grown by 44.23% in the past year. This is a very strong growth!
The Revenue has been growing by 9.87% on average over the past years. This is quite good.
EPS 1Y (TTM)42.03%
EPS 3Y29.94%
EPS 5Y6.33%
EPS Q2Q%41.12%
Revenue 1Y (TTM)44.23%
Revenue growth 3Y20.95%
Revenue growth 5Y9.87%
Sales Q2Q%17.76%

3.2 Future

MTX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.66% yearly.
Based on estimates for the next years, MTX will show a quite strong growth in Revenue. The Revenue will grow by 11.02% on average per year.
EPS Next Y25.12%
EPS Next 2Y15.96%
EPS Next 3Y13.9%
EPS Next 5Y13.66%
Revenue Next Year16.04%
Revenue Next 2Y12.73%
Revenue Next 3Y11.94%
Revenue Next 5Y11.02%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MTX.DE Yearly Revenue VS EstimatesMTX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
MTX.DE Yearly EPS VS EstimatesMTX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 23.06 indicates a rather expensive valuation of MTX.
Based on the Price/Earnings ratio, MTX is valued cheaply inside the industry as 89.80% of the companies are valued more expensively.
MTX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.34.
A Price/Forward Earnings ratio of 20.15 indicates a rather expensive valuation of MTX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MTX indicates a rather cheap valuation: MTX is cheaper than 87.76% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, MTX is valued at the same level.
Industry RankSector Rank
PE 23.06
Fwd PE 20.15
MTX.DE Price Earnings VS Forward Price EarningsMTX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTX is valued cheaply inside the industry as 83.67% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MTX is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 162.44
EV/EBITDA 14.81
MTX.DE Per share dataMTX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

MTX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTX's earnings are expected to grow with 13.90% in the coming years.
PEG (NY)0.92
PEG (5Y)3.64
EPS Next 2Y15.96%
EPS Next 3Y13.9%

2

5. Dividend

5.1 Amount

MTX has a yearly dividend return of 0.55%, which is pretty low.
MTX's Dividend Yield is comparable with the industry average which is at 1.08.
With a Dividend Yield of 0.55, MTX pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

The dividend of MTX decreases each year by -5.03%.
Dividend Growth(5Y)-5.03%
Div Incr Years0
Div Non Decr Years3
MTX.DE Yearly Dividends per shareMTX.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MTX pays out 15.38% of its income as dividend. This is a sustainable payout ratio.
DP15.38%
EPS Next 2Y15.96%
EPS Next 3Y13.9%
MTX.DE Yearly Income VS Free CF VS DividendMTX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
MTX.DE Dividend Payout.MTX.DE Dividend Payout, showing the Payout Ratio.MTX.DE Dividend Payout.PayoutRetained Earnings

MTU AERO ENGINES AG

FRA:MTX (10/14/2025, 3:21:15 PM)

380.3

-10 (-2.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-24 2025-07-24/dmh
Earnings (Next)10-23 2025-10-23/amc
Inst Owners74.81%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap20.47B
Analysts72.8
Price Target380.82 (0.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend2.18
Dividend Growth(5Y)-5.03%
DP15.38%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.07%
Min EPS beat(2)13.94%
Max EPS beat(2)16.19%
EPS beat(4)4
Avg EPS beat(4)8.2%
Min EPS beat(4)0.12%
Max EPS beat(4)16.19%
EPS beat(8)6
Avg EPS beat(8)4.51%
EPS beat(12)8
Avg EPS beat(12)5.49%
EPS beat(16)11
Avg EPS beat(16)4.95%
Revenue beat(2)2
Avg Revenue beat(2)4.21%
Min Revenue beat(2)2.45%
Max Revenue beat(2)5.98%
Revenue beat(4)3
Avg Revenue beat(4)2.12%
Min Revenue beat(4)-2.25%
Max Revenue beat(4)5.98%
Revenue beat(8)4
Avg Revenue beat(8)0.11%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.62%
PT rev (3m)7.32%
EPS NQ rev (1m)-8.84%
EPS NQ rev (3m)-6.33%
EPS NY rev (1m)0.35%
EPS NY rev (3m)10.1%
Revenue NQ rev (1m)-1.96%
Revenue NQ rev (3m)1.06%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 23.06
Fwd PE 20.15
P/S 2.51
P/FCF 162.44
P/OCF 26.31
P/B 5.33
P/tB 8.48
EV/EBITDA 14.81
EPS(TTM)16.49
EY4.34%
EPS(NY)18.88
Fwd EY4.96%
FCF(TTM)2.34
FCFY0.62%
OCF(TTM)14.46
OCFY3.8%
SpS151.65
BVpS71.4
TBVpS44.85
PEG (NY)0.92
PEG (5Y)3.64
Profitability
Industry RankSector Rank
ROA 7.23%
ROE 22.17%
ROCE 14.48%
ROIC 10.39%
ROICexc 15.22%
ROICexgc 21.84%
OM 12.25%
PM (TTM) 10.44%
GM 16.9%
FCFM 1.54%
ROA(3y)2.55%
ROA(5y)2.41%
ROE(3y)8.72%
ROE(5y)7.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y53.54%
ROICexcg growth 5Y11.08%
ROICexc growth 3Y47.75%
ROICexc growth 5Y8.65%
OM growth 3Y17.54%
OM growth 5Y-3.69%
PM growth 3Y17.24%
PM growth 5Y-3.73%
GM growth 3Y6.66%
GM growth 5Y-3.81%
F-Score6
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 19.44
Debt/EBITDA 1.57
Cap/Depr 174.33%
Cap/Sales 7.99%
Interest Coverage 250
Cash Conversion 56.62%
Profit Quality 14.79%
Current Ratio 1.39
Quick Ratio 1.04
Altman-Z 3.15
F-Score6
WACC6.76%
ROIC/WACC1.54
Cap/Depr(3y)170.27%
Cap/Depr(5y)151.83%
Cap/Sales(3y)8.23%
Cap/Sales(5y)7.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.03%
EPS 3Y29.94%
EPS 5Y6.33%
EPS Q2Q%41.12%
EPS Next Y25.12%
EPS Next 2Y15.96%
EPS Next 3Y13.9%
EPS Next 5Y13.66%
Revenue 1Y (TTM)44.23%
Revenue growth 3Y20.95%
Revenue growth 5Y9.87%
Sales Q2Q%17.76%
Revenue Next Year16.04%
Revenue Next 2Y12.73%
Revenue Next 3Y11.94%
Revenue Next 5Y11.02%
EBIT growth 1Y542.48%
EBIT growth 3Y42.17%
EBIT growth 5Y5.82%
EBIT Next Year62.22%
EBIT Next 3Y22.4%
EBIT Next 5Y18.05%
FCF growth 1Y-53.68%
FCF growth 3Y-41.04%
FCF growth 5Y-35.95%
OCF growth 1Y8.51%
OCF growth 3Y7.99%
OCF growth 5Y-3.01%